🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10364+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10364 recruiting trials

NARecruitingNCT06983366

Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases

👨‍⚕️ Ahmad M. Shaddad, MD, Assiut University📍 1 site📅 Started May 2025View details ↗
Phase 2RecruitingNCT06302569

Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma

👨‍⚕️ Giuseppe Procopio, MD, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy📍 1 site📅 Started May 2025View details ↗
Phase 1, PHASE2RecruitingNCT06969430

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

🏥 Debiopharm International SA📍 7 sites📅 Started May 2025View details ↗
NARecruitingNCT07087873

Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases

🏥 Xuanwu Hospital, Beijing📍 1 site📅 Started May 2025View details ↗
Phase 2, PHASE3RecruitingNCT06947499

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

🏥 LG Chem📍 1 site📅 Started May 2025View details ↗
EARLY_Phase 1RecruitingNCT06980155

XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia

🏥 Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started May 2025View details ↗
Phase 1, PHASE2RecruitingNCT06533579

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

👨‍⚕️ Vironexis Clinical Trials, Vironexis Biotherapeutics Inc.📍 9 sites📅 Started May 2025View details ↗
NARecruitingNCT07021820

Multispectral Optoacoustic Tomography for Advanced Imaging of Centronuclear Myopathy

👨‍⚕️ Ferdinand Knieling, PD Dr. med. habil. Dr. rer. b, Kinder- & Jugendklinik, Erlangen📍 1 site📅 Started May 2025View details ↗
Phase 2RecruitingNCT06954467

JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma

🏥 Shanghai Junshi Bioscience Co., Ltd.📍 12 sites📅 Started May 2025View details ↗
Phase 2RecruitingNCT06904872

Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)

🏥 Napo Therapeutics, S.p.A.📍 8 sites📅 Started May 2025View details ↗
Phase 3RecruitingNCT06844487

Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC

🏥 Jean-Pierre Van geertruyden📍 1 site📅 Started May 2025View details ↗
Phase 1RecruitingNCT07152288

Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HSK39297 in Subjects With Hepatic Impairment

🏥 Haisco Pharmaceutical Group Co., Ltd.📍 1 site📅 Started May 2025View details ↗
Phase 2RecruitingNCT07020923

Monthly Dosing of Atacicept in IgAN

👨‍⚕️ Zeeshan Khawaja, Vice President, Clinical Development📍 1 site📅 Started May 2025View details ↗
Phase 3RecruitingNCT06970743

A Study of BGB-16673 Compared to Investigator's Choice in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Covalent Bruton Tyrosine Kinase (BTK) Inhibitors

👨‍⚕️ Study Director Study Director, BeOne Medicines📍 64 sites📅 Started May 2025View details ↗
Phase 1, PHASE2RecruitingNCT07066982

Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas

🏥 Essen Biotech📍 1 site📅 Started May 2025View details ↗
RecruitingNCT06574373

Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression

👨‍⚕️ Carmine Carbone, PhD, Fondazione Policlinico Universitario Agostino Gemelli IRCCS📍 2 sites📅 Started May 2025View details ↗
Phase 1, PHASE2RecruitingNCT06765980

A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration

🏥 Kriya Therapeutics, Inc.📍 3 sites📅 Started May 2025View details ↗
NARecruitingNCT06822231

High-Tech Rehabilitation Pathway for Acute Adult Neuromuscular Diseases - Fit4MedRob-Acute MND Project

🏥 Istituti Clinici Scientifici Maugeri SpA📍 8 sites📅 Started May 2025View details ↗
Phase 2RecruitingNCT06782373

A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)

👨‍⚕️ Study Physician, Sobi, Inc.📍 20 sites📅 Started May 2025View details ↗
Phase 3RecruitingNCT06971094

Safety and Efficacy Evaluation of GC101 Gene Therapy Via Intrathecal (IT) Injectionin the Treatment of Patients With Type 2 Spinal Muscular Atrophy (SMA) - Phase III

👨‍⚕️ GeneCradle, Inc China📍 7 sites📅 Started May 2025View details ↗
← PreviousPage 106 of 519Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →